192 related articles for article (PubMed ID: 32907888)
1. How can we better predict pulmonary blood clots in patients hospitalised for COVID-19?
Bertoletti L; Huisman MV
Eur Respir J; 2020 Oct; 56(4):. PubMed ID: 32907888
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 and thrombosis: Beyond a casual association.
López Castro J
Med Clin (Barc); 2020 Jul; 155(1):44. PubMed ID: 32446683
[No Abstract] [Full Text] [Related]
3. COVID-19 and thrombotic complications: Pulmonary thrombosis rather than embolism?
Gabrielli M; Lamendola P; Esperide A; Valletta F; Franceschi F
Thromb Res; 2020 Sep; 193():98. PubMed ID: 32534328
[No Abstract] [Full Text] [Related]
4. Response to "All these D-dimers in COVID-19".
Zhang L
J Thromb Haemost; 2020 Aug; 18(8):2076-2077. PubMed ID: 32526058
[No Abstract] [Full Text] [Related]
5. Sars-CoV-2 Induced Coagulopathy and Prognosis in Hospitalized Patients: A Snapshot from Italy.
Giusti B; Gori AM; Alessi M; Rogolino A; Lotti E; Poli D; Sticchi E; Bartoloni A; Morettini A; Nozzoli C; Peris A; Pieralli F; Poggesi L; Marchionni N; Marcucci R
Thromb Haemost; 2020 Aug; 120(8):1233-1236. PubMed ID: 32455440
[No Abstract] [Full Text] [Related]
6. Narrowing in on the True Rate of Venous Thromboembolism in Hospitalized Patients With COVID-19 Disease.
Siegal DM; Gross PL
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):1958-1960. PubMed ID: 32762455
[No Abstract] [Full Text] [Related]
7. Pulmonary arterial thrombosis as an important complication of COVID-19 pulmonary disease: letter to the editor.
Lax SF; Skok K; Trauner M;
Virchows Arch; 2020 Sep; 477(3):467-468. PubMed ID: 32772159
[No Abstract] [Full Text] [Related]
8. Venous thromboembolism and COVID-19.
Bertoletti L; Couturaud F; Montani D; Parent F; Sanchez O
Respir Med Res; 2020 Nov; 78():100759. PubMed ID: 32474397
[No Abstract] [Full Text] [Related]
9. Coagulation abnormalities and thrombosis in patients with COVID-19.
Levi M; Thachil J; Iba T; Levy JH
Lancet Haematol; 2020 Jun; 7(6):e438-e440. PubMed ID: 32407672
[No Abstract] [Full Text] [Related]
10. The tug-of-war between coagulopathy and anticoagulant agents in patients with COVID-19.
Canonico ME; Siciliano R; Scudiero F; Sanna GD; Parodi G
Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(4):262-264. PubMed ID: 32383737
[No Abstract] [Full Text] [Related]
11. Pulmonary Embolism in Patients With Covid-19 Pneumonia: The Utility of D-dimer.
Rodriguez-Sevilla JJ; Rodó-Pin A; Espallargas I; Villar-García J; Molina L; Pérez Terán P; Vázquez Sanchez A; Masclans JR; Jiménez C; Millan Segovia R; Zuccarino F; Salar A; Rodriguez-Chiaradía DA
Arch Bronconeumol (Engl Ed); 2020 Nov; 56(11):758-759. PubMed ID: 32773301
[No Abstract] [Full Text] [Related]
12. Thromboinflammatory response in SARS-CoV-2 sepsis.
Maiese A; Passaro G; Matteis A; Fazio V; Raffaele R; Paolo MD
Med Leg J; 2020 Jul; 88(2):78-80. PubMed ID: 32490726
[TBL] [Abstract][Full Text] [Related]
13. Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new "prudent" randomised clinical trial.
Cattaneo M; Morici N
Blood Transfus; 2020 May; 18(3):237-238. PubMed ID: 32453692
[No Abstract] [Full Text] [Related]
14. COVID-19 coagulopathy: an evolving story.
The Lancet Haematology
Lancet Haematol; 2020 Jun; 7(6):e425. PubMed ID: 32470428
[No Abstract] [Full Text] [Related]
15. All those D-dimers in COVID-19.
Thachil J
J Thromb Haemost; 2020 Aug; 18(8):2075-2076. PubMed ID: 32470213
[No Abstract] [Full Text] [Related]
16. COVID-19 and arterial thrombosis: A potentially fatal combination.
Moroni F; Baldetti L
Int J Cardiol; 2021 Jan; 322():286-290. PubMed ID: 33091523
[No Abstract] [Full Text] [Related]
17. Anticoagulation in COVID-19: It Is Time for High-Quality Evidence.
Lopes RD; Fanaroff AC
J Am Coll Cardiol; 2020 Oct; 76(16):1827-1829. PubMed ID: 33059827
[TBL] [Abstract][Full Text] [Related]
18. Response to "Uncertainties on the prognostic value of D-dimers in COVID-19 patients".
Zhang L
J Thromb Haemost; 2020 Aug; 18(8):2067-2068. PubMed ID: 32407600
[No Abstract] [Full Text] [Related]
19. Response to 'The association between D-dimer in COVID-19 patients and mortality remains beset of uncertainties'.
Zhang L; Yan X; Gong Y; Zhang Z
J Thromb Haemost; 2020 Aug; 18(8):2070-2071. PubMed ID: 32608062
[No Abstract] [Full Text] [Related]
20. Superficial thrombophlebitis in a patient with COVID 19: Heparin treatment after evaluation of D-Dimer.
Demirbaş A; Elmas ÖF; Türsen Ü; Atasoy M; Lotti T
Dermatol Ther; 2020 Jul; 33(4):e13768. PubMed ID: 32500589
[No Abstract] [Full Text] [Related]
[Next] [New Search]
